1-2 of 2
Sabina Chiaretti
Close
Sort by
Journal Articles

A robust and validated integrated prognostic index for defining risk groups in adult acute lymphoblastic leukemia: an EWALL collaborative study

Clinical Trials & Observations
Amir Enshaei, Melvin Joy, Ellie Butler, Amy A. Kirkwood, Monica Messina, Chiara Pavoni, Mireia Morgades, Christine J. Harrison, Robin Foà, Josep-Maria Ribera, Sabina Chiaretti, Renato Bassan, Adele K. Fielding, Anthony V. Moorman
Journal: Blood Advances
Blood Adv (2024) 8 (5): 1155–1166.
https://doi.org/10.1182/bloodadvances.2023011661
Published: 2024
Includes: Supplemental data
Journal Articles

Pegaspargase-modified risk-oriented program for adult acute lymphoblastic leukemia: results of the GIMEMA LAL1913 trial

Clinical Trials & Observations
Renato Bassan, Sabina Chiaretti, Irene Della Starza, Orietta Spinelli, Alessandra Santoro, Francesca Paoloni, Monica Messina, Loredana Elia, Maria Stefania De Propris, Anna Maria Scattolin, Ernesta Audisio, Laura Marbello, Erika Borlenghi, Patrizia Zappasodi, Elisa Mauro, Giovanni Martinelli, Daniele Mattei, Nicola Fracchiolla, Monica Bocchia, Paolo De Fabritiis, Massimiliano Bonifacio, Anna Candoni, Vincenzo Cassibba, Paolo Di Bartolomeo, Giancarlo Latte, Silvia Trappolini, Anna Guarini, Antonella Vitale, Paola Fazi, Alfonso Piciocchi, Alessandro Rambaldi, Robin Foà
Journal: Blood Advances
Blood Adv (2023) 7 (16): 4448–4461.
https://doi.org/10.1182/bloodadvances.2022009596
Published: 2023
Includes: Supplemental data